TrialDrug design, development and therapy2022

Open-Label, Phase I, Pharmacokinetic Studies in Healthy Chinese Subjects to Evaluate the Bioequivalence and Food Effect of a Novel Formulation of Abiraterone Acetate Tablets.

Zeying Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.